<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">nss</journal-id>
      <journal-id journal-id-type="pmc">nss</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">33304112</article-id>
      <article-id pub-id-type="pmc">7723233</article-id>
      <article-id pub-id-type="publisher-id">286403</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S286403</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Positional Sleep Apnea Among Regional and Remote Australian Population and Simulated Positional Treatment Effects</article-title>
        <alt-title alt-title-type="running-authors">Garg et al</alt-title>
        <alt-title alt-title-type="running-title">Garg et al</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Garg</surname>
            <given-names>Himanshu</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Er</surname>
            <given-names>Xin Yi</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Howarth</surname>
            <given-names>Timothy</given-names>
          </name>
          <xref ref-type="aff" rid="aff0002">
            <sup>2</sup>
          </xref>
          <xref ref-type="aff" rid="aff0003">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0788-7137</contrib-id>
          <name>
            <surname>Heraganahally</surname>
            <given-names>Subash S</given-names>
          </name>
          <xref ref-type="aff" rid="aff0001">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff0003">
            <sup>3</sup>
          </xref>
          <xref ref-type="aff" rid="aff0004">
            <sup>4</sup>
          </xref>
          <xref ref-type="corresp" rid="an0001"/>
        </contrib>
        <aff id="aff0001"><label>1</label>Department of Respiratory and Sleep Medicine, <institution>Royal Darwin Hospital</institution>, <addr-line>Darwin</addr-line>, <addr-line>Northern Territory</addr-line>, <country>Australia</country></aff>
        <aff id="aff0002"><label>2</label><institution>College of Health and Human Sciences, Charles Darwin University</institution>, <addr-line>Darwin</addr-line>, <addr-line>Northern Territory</addr-line>, <country>Australia</country></aff>
        <aff id="aff0003"><label>3</label><institution>Darwin Respiratory and Sleep Health, Darwin Private Hospital, Tiwi</institution>, <addr-line>Darwin</addr-line>, <addr-line>Northern Territory</addr-line>, <country>Australia</country></aff>
        <aff id="aff0004"><label>4</label><institution>Flinders University – College of Medicine and Public Health</institution>, <addr-line>Adelaide</addr-line>, <country>South Australia</country></aff>
      </contrib-group>
      <author-notes>
        <corresp id="an0001">Correspondence: Subash S Heraganahally <institution>Department of Respiratory and Sleep Medicine, Royal Darwin Hospital</institution>, <addr-line>105, Rocklands Drive, Tiwi</addr-line>, <addr-line>Darwin</addr-line>, <addr-line>NT</addr-line>, <country>Australia</country><phone>Tel +61-8-89228888</phone><fax>Fax +61-8-89206309</fax> Email hssubhashcmc@hotmail.com</corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>04</day>
        <month>12</month>
        <year>2020</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2020</year>
      </pub-date>
      <volume>12</volume>
      <fpage>1123</fpage>
      <lpage>1135</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>10</month>
          <year>2020</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>11</month>
          <year>2020</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2020 Garg et al.</copyright-statement>
        <copyright-year>2020</copyright-year>
        <copyright-holder>Garg et al.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (<ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <sec id="s2001">
          <title>Purpose</title>
          <p><citation_analysis attribute="neither">To assess the prevalence of positional sleep apnea (POSA) and its predictors in patients diagnosed to have obstructive sleep apnea (OSA) in the regional and remote population of the Northern Territory of Australia over a two-year study period (2018 and 2019).</citation_analysis></p>
        </sec>
        <sec id="s2002">
          <title>Patients and Methods</title>
          <p><citation_analysis attribute="positive">Of the total 1463 adult patients who underwent a diagnostic polysomnography (PSG), 946 patients were eligible to be included in the study, of them, 810 consecutive patients with OSA (Apnea-Hypopnea Index (AHI) ≥ 5) who slept &gt;4 h and had ≥30 min sleep in both supine and lateral positions were assessed. Patients were considered to have POSA if supine AHI to lateral AHI ratio ≥2. The likely comparative impact of use of continuous positive airway therapy (CPAP) or positional therapy (PT) on disease severity was evaluated using model simulation.</citation_analysis></p>
        </sec>
        <sec id="s2003">
          <title>Results</title>
          <p><citation_analysis attribute="positive">A total of 495/810 (61%) patients had POSA, the majority were males (68% vs 60%, p=0.013) and non-Indigenous Australians (93% vs 87%, p=0.004). POSA patients were younger (mean difference 2.23 years (95% CI 0.27, 4.19)), less obese (BMI mean difference 3.06 (95% CI 2.11, 4.01)), demonstrated less severe OSA (p &lt; 0.001) and a greater proportion reported alcohol consumption (72% vs 62%, p=0.001) as compared to those with non-POSA. Using the simulation model, if patients with POSA use PT two-thirds (323/495, 65%) would obtain significant improvement of their OSA severity, with one in five (92/495, 19%) displaying complete resolution. Comparing this to simulated CPAP therapy, where the majority (444/495, 90%) will show significant improvement, and one-third (162/495, 33%) will display complete resolution.</citation_analysis></p>
        </sec>
        <sec id="s2004">
          <title>Conclusion</title>
          <p><citation_analysis attribute="neither">POSA needs to be routinely recognised and positional therapy integrated in practice especially in the remote regions and in the developing world when effective methods are in place to monitor positional therapy.</citation_analysis></p>
        </sec>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords</title>
        <kwd>adherence: apnea hypopnea index</kwd>
        <kwd>body mass index</kwd>
        <kwd>continuous positive airway pressure</kwd>
        <kwd>obstructive sleep apnea</kwd>
        <kwd>positional therapy</kwd>
      </kwd-group>
      <counts>
        <fig-count count="2"/>
        <table-count count="15"/>
        <ref-count count="60"/>
        <page-count count="13"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="s0001">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">The global prevalence of obstructive sleep apnea (OSA) is estimated to be between 6 and 17% across various populations, particularly affecting those who are ageing or have a higher body mass index (BMI).</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0001" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0002" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither"> OSA is known to interact with and predisposes to cardiovascular diseases leading to reduced quality of life and higher mortality.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0003" ref-type="bibr">3–6</xref></citation_analysis><citation_analysis attribute="neither"> A growing body of literature exists to define the determinants and phenotypes of sleep apnea to better develop personalised treatment options for patients diagnosed with OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0007" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0008" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither"> Body position is known to impact the severity of OSA and supine sleep is observed to be associated with higher apnea-hypopnea index (AHI)</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0009" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither">, moreover, body position parameters are recommended to be measured routinely among patients undergoing polysomnography (PSG) testing.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0010" ref-type="bibr">10</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">A distinct clinical type of OSA, “positional sleep apnea” (POSA) is considered when respiratory events occur predominantly in certain body position during sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0009" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="neither"> There are currently multiple clinical definitions of POSA; however, regardless of which definition is used, prevalence of POSA typically exceeds 50% among patients undergoing a PSG and diagnosed to have OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12–15</xref></citation_analysis><citation_analysis attribute="neither"> It is also observed that in supine sleep, apneas and arousals are longer, desaturations are deeper, snoring is louder, and occurrence of tachy-bradycardia following an apnoeic episode are more severe compared to lateral sleep position.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Continuous positive airway pressure (CPAP) therapy is a well-established treatment modality for OSA and has been shown to improve quality of life in these patients.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0017" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0018" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither"> However, acceptance and long-term adherence to CPAP therapy can be variable.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0019" ref-type="bibr">19–22</xref></citation_analysis><citation_analysis attribute="positive"> Previous studies have reported non-adherence rates to CPAP therapy can range between 34 and 83%.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0023" ref-type="bibr">23</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither"> Consequently, a substantial proportion of patients with OSA who are either untreated or non-adherent to CPAP can experience adverse health consequences.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0025" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="neither"> Moreover, the affordability and accessibility to a CPAP device can be a major issue, especially among the socioeconomically disadvantaged and people living in regional and remote communities.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0026" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0027" ref-type="bibr">27</xref></citation_analysis><citation_analysis attribute="neither"> However, alternate therapeutic interventions may be helpful in addressing this issue.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">OSA is highly prevalent among the adult Australian population.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30</xref></citation_analysis><citation_analysis attribute="positive"> However, there is sparse published evidence in the literature in relation to POSA in the regional and remote Australian setting. Previous studies from our centre at the Top End Health Service (TEHS) region of the Northern Territory (NT) of Australia have demonstrated a higher proportion of OSA among both Australian Aboriginal and/or Torres Strait Islander (ATSI) (henceforth represented as Indigenous Australians with respect) and non-Indigenous population.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31–33</xref></citation_analysis><citation_analysis attribute="neither"> The population profile of the Top End, NT of Australia is unique and diverse, with a population of about 249,220 people and about 30% of whom are of Indigenous Australian descent living in an area stretched over 245,000 km</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither"> (94,595.0 sq miles) in the northern, sub-tropical part of Australia.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0034" ref-type="bibr">34</xref></citation_analysis><citation_analysis attribute="positive"> Moreover, 81% of Indigenous Australians and a minor proportion of non-Indigenous people live in remote and regional communities that can be accessed only by seasonal light aircraft. Hence, access to and monitoring of therapeutic interventions such as CPAP therapy possess unprecedented challenges due to the logistics involved. However, positional therapy (PT) may provide a viable alternative option in this population for those diagnosed to have OSA given the high rates of OSA reported in the literature, that may potentially change the treatment paradigm for OSA in this region. Initially however, it is critical to assess the prevalence of POSA in this population for further interventions. Hence, in this study, we evaluated the demographic, clinical and PSG characteristics and the presence of POSA among patients who underwent a diagnostic sleep study (PSG) in our centre. Furthermore, we also made an attempt to explore a model simulated scenario to understand if PT would be beneficial in this population.</citation_analysis></p>
    </sec>
    <sec id="s0002">
      <title>Patients and Methods</title>
      <sec id="s0002-s2001">
        <title>Setting and Study Participants</title>
        <p><citation_analysis attribute="positive">This retrospective study was conducted at the Royal Darwin Hospital (RDH) and Darwin Respiratory and Sleep Health (DRSH), Darwin Private Hospital (DPH) in the TEHS region of the NT of Australia. Patients over 18 years of age from the TEHS region who underwent a diagnostic PSG over a 2-year (2018–2019) study period were included in this study. As per usual practice in our centre, patients underwent a diagnostic PSG after an initial clinical consultation with a Respiratory and Sleep Specialist based at the RDH/DPH. The patients were referred to the respiratory and sleep service at RDH and DRSH/DPH by primary health physicians, general practitioners and specialist practitioners for clinically suspected sleep disorders.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2002">
        <title>Clinical Parameters</title>
        <p><citation_analysis attribute="positive">As per usual protocol in this centre, clinical and demographic characteristics including self-identified ethnic status, age, sex, height, weight, BMI (underweight (BMI≤18.5), normal weight (BMI&gt;18.5 and BMI≤25), overweight (BMI&gt;25 and BMI≤30), Obese I (BMI&gt;30 and BMI≤35) and Obese II (BMI&gt;35)), neck circumference and medical co-morbid conditions were recorded for all patients undergoing a sleep study. Self-reported Epworth Sleepiness Scale (ESS) score, alcohol history and smoking status were also recorded. Patient’s residence locality was identified by post code and they were classified as either living in urban, outer rural Regional Australia (RA 2, 3) or remote (RA4) and very remote (RA5), in accordance within the TEHS regions.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0035" ref-type="bibr">35</xref></citation_analysis></p>
      </sec>
      <sec id="s0002-s2003">
        <title>Polysomnography (PSG) Data</title>
        <p><citation_analysis attribute="positive">All PSGs were performed at the Darwin-based sleep service facility, DRSH based at the DPH, an accredited sleep testing facility by the National Association of Testing Authorities, Australia (NATA) and the Australian Sleep Association (ASA). Sleep studies were performed and analysed in accordance with the American Academy of Sleep Medicine recommendations and as described in previous reports from our centre.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="positive"> Polysomnography data were extracted to include information on the severity of sleep disordered breathing using Apnea-Hypopnea Index (AHI) criteria. Total AHI was categorised into four groups: AHI ≤5 (normal range), AHI = 5–14.9 (mild sleep apnea), AHI = 15–29.9 (moderate sleep apnea), AHI ≥ 30 (severe sleep apnea). PSG parameters for sleep architectures were also assessed. Only level 1 (monitored “in-lab”) and level 2 (unmonitored ambulatory home) studies were included in the analysis. In order to accurately determine prevalence of POSA the following additional study inclusion criteria were applied: total sleep time ≥4 hours, and recorded time in supine and lateral positions ≥30 minutes each.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2004">
        <title>POSA and Non-POSA Consideration</title>
        <p><citation_analysis attribute="neither">Utilising a modified Cartwright definition</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0009" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither"> POSA was defined as; total AHI ≥5, and supine to lateral AHI ratio of ≥2:1. Non-POSA was defined as presence of OSA which did not meet the preceding criteria.</citation_analysis></p>
      </sec>
      <sec id="s0002-s2005">
        <title>Treatment Simulation</title>
        <p><citation_analysis attribute="positive">The likely impacts on disease severity of treatment modalities were simulated in the present study. In order to give meaningful comparisons and account appropriately for real-world scenarios, optimal usage of both PT and CPAP therapy were set to be the same (60%) for the duration of sleep. The impact of PT was simulated assuming that therapy caused patients to sleep in the (non-supine) lateral position 60% of the night; thus, the PT simulated AHI was calculated using the formula: </citation_analysis><citation_analysis attribute="positive"><inline-formula id="ilm0001"><alternatives><inline-graphic xlink:href="NSS-12-1123-e0001.jpg"/><tex-math id="M1">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$$AH{I_{PT}} = (AH{I_{Supine}}*0.4) + AH{I_{Lateral}}$$
\end{document}</tex-math></alternatives></inline-formula></citation_analysis><citation_analysis attribute="neither">. The simulation of the CPAP effect was based on the assumption that the frequency of apnea/hypopnea events is constant throughout the night. Furthermore, it was assumed that CPAP with optimal pressure prevents all respiratory events, and no apneas or hypopneas occur during simulated CPAP usage. CPAP adherence was considered optimal for 60% of the total sleep time.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0036" ref-type="bibr">36</xref></citation_analysis><citation_analysis attribute="positive"> Therefore, total AHI in this CPAP simulation was calculated using the formula: </citation_analysis><citation_analysis attribute="positive"><inline-formula id="ilm0002"><alternatives><inline-graphic xlink:href="NSS-12-1123-e0002.jpg"/><tex-math id="M2">\documentclass[12pt]{minimal}
\usepackage{wasysym}
\usepackage[substack]{amsmath}
\usepackage{amsfonts}
\usepackage{amssymb}
\usepackage{amsbsy}
\usepackage[mathscr]{eucal}
\usepackage{mathrsfs}
\DeclareFontFamily{T1}{linotext}{}
\DeclareFontShape{T1}{linotext}{m}{n} {linotext }{}
\DeclareSymbolFont{linotext}{T1}{linotext}{m}{n}
\DeclareSymbolFontAlphabet{\mathLINOTEXT}{linotext}
\begin{document}
$$AH{I_{Simulated}} = AH{I_{Total}}*0.4$$
\end{document}</tex-math></alternatives></inline-formula></citation_analysis></p>
      </sec>
      <sec id="s0002-s2006">
        <title>Statistical Consideration</title>
        <p><citation_analysis attribute="positive">Continuous parameters were initially analysed for normality via the Shapiro Wilks distribution test, and all were found to have non-parametric distribution (p&lt;0.01) thus reported as medians (interquartile ranges (IQRs)) while categorical variables were reported as numbers (percentages). BMI was reported both as a continuous parameter and as categorical parameters.</citation_analysis></p>
        <p><citation_analysis attribute="positive">Demographic and clinical parameters were compared between POSA and non-POSA (excluding non-OSA participants) using equality of medians test for continuous parameters, and two-tailed proportions z-test for categorical parameters. Univariate and multivariate logistic regression models were developed to define the individual and combined effects of demographic and clinical parameters on presence of POSA reporting odds ratios (ORs) and 95% confidence intervals (95% CIs), parameter p-values, model p-value and Pearson’s pseudo R</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither">. Predictive patterns of the univariate and multivariate models were graphically represented in coefficients plots.</citation_analysis></p>
        <p><citation_analysis attribute="positive">PSG parameters were compared between POSA and non-POSA (excluding non-OSA participants) using equality of medians test and Wilcoxon rank-sum equality of distributions test, reporting p-values for each. Oxygen saturation parameters were further graphically represented utilising kernel density graphs comparing POSA and non-POSA participants.</citation_analysis></p>
        <p><citation_analysis attribute="positive">Treatment simulation was explored for participants with POSA, comparing post-treatment AHI and absolute AHI reduction between PT and CPAP therapy via equality of median tests and Wilcoxon rank-sum equality of distributions test. The proportions of the number of participants who would demonstrate reduction of one severity level (ie, severe (AHI≥30) to moderate (AHI 15–29.9)) and the proportions of those who would demonstrate any reduction in severity level (ie, severe (AHI≥30) to moderate (AHI 15–29.9), severe to mild (AHI 5–14.9) and severe to absent (AHI&lt;5) summed) were tested between PT and CPAP therapy using two-tailed proportions z-test. All analysis was conducted in STATA IC 15.1 (StataCorp Texas).</citation_analysis></p>
      </sec>
      <sec id="s0002-s2007">
        <title>Ethical Approval</title>
        <p><citation_analysis attribute="positive">This study was approved by the Human Research Ethics Committee of the NT Department of Health/TEHS and Menzies School of Health Research (HREC 2020–3671) and was conducted in accordance with the Declaration of Helsinki. Individual consent from the study participants was not obtained, as the study was retrospective in nature and no active positional therapy device or CPAP interventions were investigated during this study. Investigators involved in this study are the usual specialist physicians for the patients included in this study and have access to patients’ medical records and sleep study reports as a part of their usual medical care. Hence, separate patients’ consent to access their medical records or the sleep study reports was not required and was approved by local ethics committee.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0003">
      <title>Results</title>
      <sec id="s0003-s2001">
        <title>Clinical Characteristics of the Study Participants</title>
        <p><citation_analysis attribute="neither">A total of 1463 adult patients (≥18 years old) underwent a diagnostic sleep study with complete PSG recording at the DRSH centre between January 2018 and December 2019. Of these; 3% (n=39) sleep studies failed, 3% (n=42) had no positional data, 11% (n=161) recorded &lt;30 minutes in supine position, 15% (n=212) recorded &lt;30 minutes in other sleep positions, 2% (n=28) had &lt;4 hours total sleep and 2% (n=35) had discrepancies in records between overall and positional sleep and were excluded from further analysis, resulting in complete records for 65% (n=946) of participants.</citation_analysis></p>
        <p><citation_analysis attribute="neither">The majority of participants were male (62%, n=583), non-Indigenous Australian (92%, n=886) and lived in the urban Darwin region (90%, n=852) (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0001" ref-type="table">Table 1</xref></citation_analysis><citation_analysis attribute="neither">). Participants tended to be middle-aged (48 years IQR 37, 58.7), overweight (BMI 31.37, IQR 27.67, 36.29) and almost half (44%, n=413) had at least one comorbidity (Heart disease, hypertension, diabetes or mental health issues). A total of 86% (n=810) of participants were recorded to have OSA, of which 36% (n=291) were mild, 29% (n=233) moderate, and 35% (n=286) severe.</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0001" orientation="portrait" position="float"><label>Table 1</label><caption><p><citation_analysis attribute="neither">Clinical and Demographic Characteristics of the Study Participants</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Parameters</th><th rowspan="1" colspan="1">Variables</th><th rowspan="1" colspan="1">Participants (n=946)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age</td><td rowspan="1" colspan="1">Years</td><td rowspan="1" colspan="1">48 (37, 58.7)</td></tr><tr><td rowspan="1" colspan="1">Sex</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">583 (62%)</td></tr><tr><td rowspan="1" colspan="1">Ethnicity</td><td rowspan="1" colspan="1">Indigenous Australian</td><td rowspan="1" colspan="1">60 (8%)</td></tr><tr><td rowspan="1" colspan="1">Location</td><td rowspan="1" colspan="1">Urban Darwin region</td><td rowspan="1" colspan="1">852 (90%)</td></tr><tr><td rowspan="1" colspan="1">Comorbidities</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Diabetes</td><td rowspan="1" colspan="1">83 (9%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Hypertension</td><td rowspan="1" colspan="1">145 (15%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Heart disease</td><td rowspan="1" colspan="1">75 (8%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Mental health issues</td><td rowspan="1" colspan="1">234 (25%)</td></tr><tr><td rowspan="1" colspan="1">Lifestyle risk factors</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Former smoker</td><td rowspan="1" colspan="1">338 (36%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Current smoker</td><td rowspan="1" colspan="1">169 (18%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Alcohol history</td><td rowspan="1" colspan="1">645 (69%)</td></tr><tr><td rowspan="1" colspan="1">Corpulence</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">BMI</td><td rowspan="1" colspan="1">31.37 (27.67, 36.29)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Underweight</td><td rowspan="1" colspan="1">14 (2%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Normal weight</td><td rowspan="1" colspan="1">90 (10%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Overweight</td><td rowspan="1" colspan="1">264 (29%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Obese I</td><td rowspan="1" colspan="1">262 (29%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Obese II</td><td rowspan="1" colspan="1">281 (31%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Neck Circumference (cms)</td><td rowspan="1" colspan="1">40 (37, 43)</td></tr><tr><td rowspan="1" colspan="1">OSA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Overall total AHI</td><td rowspan="1" colspan="1">17.5 (8, 34.3)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">OSA diagnosed</td><td rowspan="1" colspan="1">810 (86%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Mild</td><td rowspan="1" colspan="1">291 (36%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Moderate</td><td rowspan="1" colspan="1">233 (29%)</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Severe</td><td rowspan="1" colspan="1">286 (35%)</td></tr></tbody></table><table-wrap-foot><fn id="tfn0001"><p><citation_analysis attribute="positive"><bold>Note:</bold></citation_analysis><citation_analysis attribute="neither"> Data presented as median (IQR) and number (%).</citation_analysis></p></fn><fn id="tfn0002"><p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="neither"> AHI, Apnea-Hypopnea Index; BMI, body mass index; OSA, obstructive sleep apnea.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
      <sec id="s0003-s2002">
        <title>Positional Obstructive Sleep Apnea Data</title>
        <p><citation_analysis attribute="neither">POSA was calculated to be present in 61% (n=495) of the study cohort with OSA. The clinical characteristics of individuals with POSA compared to those with non-POSA differed significantly (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0002" ref-type="table">Table 2</xref></citation_analysis><citation_analysis attribute="positive">). A significantly higher proportion of participants with POSA were male (68% vs 60%, p=0.013), non-Indigenous (93% vs 87%, p=0.004) and reported consuming alcohol (72% vs 62%, p=0.001). POSA participants had a lower prevalence of comorbidities, significantly reduced BMI (30.84 (27.46, 35.11) vs 34.72 (30.31, 39.74), p&lt;0.001) and had milder severity of OSA.</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0002" orientation="portrait" position="float"><label>Table 2</label><caption><p><citation_analysis attribute="neither">Comparison of Clinical and Demographic Factors Between POSA and Non-POSA</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Clinical Details</th><th rowspan="1" colspan="1">Parameters</th><th rowspan="1" colspan="1">POSA (n=495)</th><th rowspan="1" colspan="1">Non-POSA (n=315)</th><th rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age</td><td rowspan="1" colspan="1">Years</td><td rowspan="1" colspan="1">49 (38, 59)</td><td rowspan="1" colspan="1">50 (39.6, 60)</td><td rowspan="1" colspan="1">0.313</td></tr><tr><td rowspan="1" colspan="1">Sex</td><td rowspan="1" colspan="1">Male</td><td rowspan="1" colspan="1">335 (68%)</td><td rowspan="1" colspan="1">189 (60%)</td><td rowspan="1" colspan="1">0.013*</td></tr><tr><td rowspan="1" colspan="1">Ethnicity</td><td rowspan="1" colspan="1">Indigenous Australian</td><td rowspan="1" colspan="1">26 (7%)</td><td rowspan="1" colspan="1">31 (13%)</td><td rowspan="1" colspan="1">0.004*</td></tr><tr><td rowspan="1" colspan="1">Location</td><td rowspan="1" colspan="1">Urban Darwin region</td><td rowspan="1" colspan="1">448 (91%)</td><td rowspan="1" colspan="1">281 (89%)</td><td rowspan="1" colspan="1">0.274</td></tr><tr><td rowspan="1" colspan="1">Comorbidities</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Diabetes</td><td rowspan="1" colspan="1">38 (8%)</td><td rowspan="1" colspan="1">41 (13%)</td><td rowspan="1" colspan="1">0.006*</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Hypertension</td><td rowspan="1" colspan="1">62 (13%)</td><td rowspan="1" colspan="1">73 (23%)</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Heart disease</td><td rowspan="1" colspan="1">39 (8%)</td><td rowspan="1" colspan="1">31 (10%)</td><td rowspan="1" colspan="1">0.169</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Mental health issues</td><td rowspan="1" colspan="1">122 (25%)</td><td rowspan="1" colspan="1">74 (24%)</td><td rowspan="1" colspan="1">0.363</td></tr><tr><td rowspan="1" colspan="1">Lifestyle risk factors</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Former smoker</td><td rowspan="1" colspan="1">180 (37%)</td><td rowspan="1" colspan="1">117 (37%)</td><td rowspan="1" colspan="1">0.428</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Current smoker</td><td rowspan="1" colspan="1">96 (19%)</td><td rowspan="1" colspan="1">63 (20%)</td><td rowspan="1" colspan="1">0.427</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Consumes alcohol</td><td rowspan="1" colspan="1">355 (72%)</td><td rowspan="1" colspan="1">194 (62%)</td><td rowspan="1" colspan="1">0.001*</td></tr><tr><td rowspan="1" colspan="1">Corpulence</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">BMI</td><td rowspan="1" colspan="1">30.84 (27.46, 35.11)</td><td rowspan="1" colspan="1">34.72 (30.31, 39.74)</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Underweight</td><td rowspan="1" colspan="1">8 (2%)</td><td rowspan="1" colspan="1">1 (0%)</td><td rowspan="1" colspan="1">0.045*</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Normal weight</td><td rowspan="1" colspan="1">44 (9%)</td><td rowspan="1" colspan="1">12 (4%)</td><td rowspan="1" colspan="1">0.003*</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Overweight</td><td rowspan="1" colspan="1">150 (31%)</td><td rowspan="1" colspan="1">59 (20%)</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Obese I</td><td rowspan="1" colspan="1">152 (32%)</td><td rowspan="1" colspan="1">84 (28%)</td><td rowspan="1" colspan="1">0.141</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Obese II</td><td rowspan="1" colspan="1">125 (26%)</td><td rowspan="1" colspan="1">143 (48%)</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Neck circumference (cms)</td><td rowspan="1" colspan="1">40 (37, 42.5)</td><td rowspan="1" colspan="1">41 (38, 45)</td><td rowspan="1" colspan="1">0.016*</td></tr><tr><td rowspan="1" colspan="1">OSA</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Overall total AHI</td><td rowspan="1" colspan="1">17.6 (10.8, 30.7)</td><td rowspan="1" colspan="1">30.1 (14.5, 61.4)</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Mild</td><td rowspan="1" colspan="1">210 (42%)</td><td rowspan="1" colspan="1">81 (26%)</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Moderate</td><td rowspan="1" colspan="1">157 (32%)</td><td rowspan="1" colspan="1">76 (24%)</td><td rowspan="1" colspan="1">0.010*</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Severe</td><td rowspan="1" colspan="1">128 (26%)</td><td rowspan="1" colspan="1">158 (50%)</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr></tbody></table><table-wrap-foot><fn id="tfn0003"><p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="positive"> Data presented as median (IQR) and number (%). Parameters analysed by group via equality of medians test (continuous data) or proportions test (categorical data). *Denotes statistically significant (p&lt;0.05) differences.</citation_analysis></p></fn><fn id="tfn0004"><p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="neither"> AHI, Apnea-Hypopnea Index; BMI, body mass index; OSA, obstructive sleep apnea; POSA, positional obstructive sleep apnea.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
        <p><citation_analysis attribute="negative">Logistic regression identified few predictive factors for POSA in our study cohort. In univariate models’ female sex, Indigenous status, presence of diabetes or hypertension and increased corpulence were all significantly and negatively correlated with POSA (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0003" ref-type="table">Table 3</xref></citation_analysis><citation_analysis attribute="neither">). Alcohol consumption was the single predictor significantly and positively associated with POSA (OR 1.59, 95% CI 1.18, 2.15, p=0.003). The fit of the model was consistently minor however, with R</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither"> ranging from 0.005 (female sex) to 0.055 (BMI). On adjustment in the combined model only increasing BMI retained significance with obesity class II (BMI&gt;35) significantly and negatively correlated with POSA (OR 0.29, 95% CI 0.13, 0.62, p=0.002) (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f0001">Figure 1</xref></citation_analysis><citation_analysis attribute="neither">). Overall fit remained low, though the model reached significance (R</citation_analysis><citation_analysis attribute="positive"><sup>2</sup></citation_analysis><citation_analysis attribute="neither">=0.066, p&lt;0.001).</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0003" orientation="portrait" position="float"><label>Table 3</label><caption><p><citation_analysis attribute="neither">Logistic Regression Models Displaying Odds Ratios and Confidence Intervals for Clinical and Demographic Factors on Presence of POSA</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">Clinical Details</th><th rowspan="1" colspan="1">Parameters</th><th colspan="2" rowspan="1">Univariate Model</th><th colspan="2" rowspan="1">Multivariate Model</th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">OR (95% CI)</th><th rowspan="1" colspan="1">p-value</th><th rowspan="1" colspan="1">OR (95% CI)</th><th rowspan="1" colspan="1">p-value</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age</td><td rowspan="1" colspan="1">Years</td><td rowspan="1" colspan="1">0.99 (0.98, 1.00)</td><td rowspan="1" colspan="1">0.081</td><td rowspan="1" colspan="1">0.99 (0.98, 1.01)</td><td rowspan="1" colspan="1">0.473</td></tr><tr><td rowspan="1" colspan="1">Sex</td><td rowspan="1" colspan="1">Male reference</td><td rowspan="1" colspan="1">0.72 (0.53, 0.96)</td><td rowspan="1" colspan="1">0.026*</td><td rowspan="1" colspan="1">0.84 (0.58, 1.23)</td><td rowspan="1" colspan="1">0.371</td></tr><tr><td rowspan="1" colspan="1">Ethnicity</td><td rowspan="1" colspan="1">Non-Indigenous reference</td><td rowspan="1" colspan="1">0.48 (0.28, 0.84)</td><td rowspan="1" colspan="1">0.009*</td><td rowspan="1" colspan="1">0.67 (0.36, 1.23)</td><td rowspan="1" colspan="1">0.195</td></tr><tr><td rowspan="1" colspan="1">Location</td><td rowspan="1" colspan="1">Remote reference</td><td rowspan="1" colspan="1">1.15 (0.72, 1.84)</td><td rowspan="1" colspan="1">0.548</td><td rowspan="1" colspan="1">1.56 (0.88, 2.75)</td><td rowspan="1" colspan="1">0.130</td></tr><tr><td rowspan="1" colspan="1">Comorbidities</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Diabetes</td><td rowspan="1" colspan="1">0.56 (0.35, 0.89)</td><td rowspan="1" colspan="1">0.013*</td><td rowspan="1" colspan="1">0.56 (0.31, 1.03)</td><td rowspan="1" colspan="1">0.061</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Hypertension</td><td rowspan="1" colspan="1">0.48 (0.33, 0.69)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">0.65 (0.4, 1.04)</td><td rowspan="1" colspan="1">0.072</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Heart Disease</td><td rowspan="1" colspan="1">0.79 (0.48, 1.29)</td><td rowspan="1" colspan="1">0.338</td><td rowspan="1" colspan="1">0.9 (0.5, 1.64)</td><td rowspan="1" colspan="1">0.738</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Depression</td><td rowspan="1" colspan="1">1.06 (0.76, 1.48)</td><td rowspan="1" colspan="1">0.727</td><td rowspan="1" colspan="1">1.23 (0.81, 1.85)</td><td rowspan="1" colspan="1">0.333</td></tr><tr><td rowspan="1" colspan="1">Lifestyle risk factors</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="2" colspan="1">Non-smoker reference</td><td rowspan="1" colspan="1">Former smoker</td><td rowspan="1" colspan="1">0.96 (0.70, 1.31)</td><td rowspan="1" colspan="1">0.786</td><td rowspan="1" colspan="1">1.03 (0.69, 1.52)</td><td rowspan="1" colspan="1">0.889</td></tr><tr><td rowspan="1" colspan="1">Current smoker</td><td rowspan="1" colspan="1">0.95 (0.65, 1.39)</td><td rowspan="1" colspan="1">0.785</td><td rowspan="1" colspan="1">0.85 (0.53, 1.36)</td><td rowspan="1" colspan="1">0.496</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Consumes alcohol</td><td rowspan="1" colspan="1">1.59 (1.18, 2.15)</td><td rowspan="1" colspan="1">0.003*</td><td rowspan="1" colspan="1">1.25 (0.85, 1.85)</td><td rowspan="1" colspan="1">0.252</td></tr><tr><td rowspan="1" colspan="1">Corpulence</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Continuous</td><td rowspan="1" colspan="1">BMI<sup>^</sup></td><td rowspan="1" colspan="1">0.92 (0.90, 0.94)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="3" colspan="1">Normal weight reference</td><td rowspan="1" colspan="1">Overweight</td><td rowspan="1" colspan="1">0.64 (0.32, 1.25)</td><td rowspan="1" colspan="1">0.190</td><td rowspan="1" colspan="1">0.69 (0.31, 1.52)</td><td rowspan="1" colspan="1">0.356</td></tr><tr><td rowspan="1" colspan="1">Obese I</td><td rowspan="1" colspan="1">0.45 (0.23, 0.88)</td><td rowspan="1" colspan="1">0.019*</td><td rowspan="1" colspan="1">0.52 (0.24, 1.12)</td><td rowspan="1" colspan="1">0.095</td></tr><tr><td rowspan="1" colspan="1">Obese II</td><td rowspan="1" colspan="1">0.22 (0.11, 0.42)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">0.29 (0.13, 0.62)</td><td rowspan="1" colspan="1">0.002*</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Neck circumference^</td><td rowspan="1" colspan="1">0.93 (0.91, 0.97)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1">OSA symptom severity</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">ESS</td><td rowspan="1" colspan="1">0.98 (0.96, 1.01)</td><td rowspan="1" colspan="1">0.199</td><td rowspan="1" colspan="1">0.99 (0.96, 1.02)</td><td rowspan="1" colspan="1">0.536</td></tr></tbody></table><table-wrap-foot><fn id="tfn0005"><p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><sup>^</sup></citation_analysis><citation_analysis attribute="positive">Continuous BMI and Neck circumference excluded from the multivariate regression due to improved fit of categorical factors and collinearity respectively. *Denotes statistically significant (p&lt;0.05) differences.</citation_analysis></p></fn><fn id="tfn0006"><p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="neither"> POSA, positional obstructive sleep apnea; OR, odds ratio; CI, confidence interval; BMI, body mass Index; OSA, obstructive sleep apnea; ESS, Epworth Sleepiness Scale.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><fig id="f0001" fig-type="figure" orientation="portrait" position="float"><label>Figure 1
</label><caption><p><citation_analysis attribute="positive">Univariate and multivariate logistic regression effects of clinical and demographic factors on odds of POSA outcome</citation_analysis></p></caption><graphic content-type="print-only" xlink:href="NSS-12-1123-g0001"/></fig></citation_analysis></p>
        <p><citation_analysis attribute="neither">Significant differences were noted between participants with POSA and those without POSA in PSG parameters (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0004" ref-type="table">Table 4</xref></citation_analysis><citation_analysis attribute="positive">). Participants with POSA spent significantly less time in non-rapid eye movement (NREM) stage-N2 sleep (p=0.047) and more in NREM-N3 (p&lt;0.001). Though there was no significant difference in the median proportion of time spent in REM sleep, there was a significant difference in the distribution between groups. Participants with POSA had reduced AHI’s in total and in each of rapid eye movement (REM) and non-rapid eye movement (NREM) sleep stages (p&lt;0.001), and reduced total arousal indexes (p=0.031); however, they had heightened spontaneous arousals (p=0.001). Oxygen saturation was greater at each measured point for participants with POSA (p&lt;0.001), and distribution plots show a significantly shortened low end tail (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f0002">Figure 2</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0004" orientation="portrait" position="float"><label>Table 4</label><caption><p><citation_analysis attribute="neither">Comparison of PSG Parameters Between Participants with POSA and Non-POSA</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">PSG Results</th><th rowspan="1" colspan="1">POSA</th><th rowspan="1" colspan="1">Non-POSA</th><th rowspan="1" colspan="1">p-value<sup>a</sup></th><th rowspan="1" colspan="1">p-value<sup>b</sup></th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Sleep latency (mins)</td><td rowspan="1" colspan="1">16.5 (6, 33)</td><td rowspan="1" colspan="1">16.5 (6.5, 38.5)</td><td rowspan="1" colspan="1">0.994</td><td rowspan="1" colspan="1">0.606</td></tr><tr><td rowspan="1" colspan="1">REM latency (mins)</td><td rowspan="1" colspan="1">111 (77.5, 175.5)</td><td rowspan="1" colspan="1">117.75 (81, 182.5)</td><td rowspan="1" colspan="1">0.346</td><td rowspan="1" colspan="1">0.189</td></tr><tr><td rowspan="1" colspan="1">Wake after sleep onset (mins)</td><td rowspan="1" colspan="1">47.5 (25, 84)</td><td rowspan="1" colspan="1">47 (25, 87.5)</td><td rowspan="1" colspan="1">0.885</td><td rowspan="1" colspan="1">0.420</td></tr><tr><td rowspan="1" colspan="1">Sleep efficiency (%)</td><td rowspan="1" colspan="1">85.8 (75.8, 91.9)</td><td rowspan="1" colspan="1">84.4 (74.9, 91.1)</td><td rowspan="1" colspan="1">0.236</td><td rowspan="1" colspan="1">0.231</td></tr><tr><td rowspan="1" colspan="1">Total sleep time (mins)</td><td rowspan="1" colspan="1">406.5 (353.5, 449.5)</td><td rowspan="1" colspan="1">405 (355.5, 451)</td><td rowspan="1" colspan="1">0.707</td><td rowspan="1" colspan="1">0.794</td></tr><tr><td rowspan="1" colspan="1">NREM-N1 Sleep %</td><td rowspan="1" colspan="1">8.8 (5.2, 12.8)</td><td rowspan="1" colspan="1">8.6 (5.1, 13.5)</td><td rowspan="1" colspan="1">0.829</td><td rowspan="1" colspan="1">0.759</td></tr><tr><td rowspan="1" colspan="1">NREM-N2 Sleep %</td><td rowspan="1" colspan="1">58.9 (50.6, 66)</td><td rowspan="1" colspan="1">61.2 (52.8, 70.6)</td><td rowspan="1" colspan="1">0.047*</td><td rowspan="1" colspan="1">0.001*</td></tr><tr><td rowspan="1" colspan="1">NREM-N3 Sleep %</td><td rowspan="1" colspan="1">12.4 (5.4, 18.9)</td><td rowspan="1" colspan="1">8.4 (0.4, 16.4)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1">REM Sleep %</td><td rowspan="1" colspan="1">18.5 (14.2, 23.3)</td><td rowspan="1" colspan="1">17.8 (12.1, 22.1)</td><td rowspan="1" colspan="1">0.471</td><td rowspan="1" colspan="1">0.043*</td></tr><tr><td rowspan="1" colspan="1">Respiratory arousal index</td><td rowspan="1" colspan="1">7.8 (3.6, 13.9)</td><td rowspan="1" colspan="1">10.4 (3.6, 29.8)</td><td rowspan="1" colspan="1">0.013*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1">Spontaneous arousal index</td><td rowspan="1" colspan="1">6.2 (4.2, 8.9)</td><td rowspan="1" colspan="1">5.1 (3.1, 7.7)</td><td rowspan="1" colspan="1">0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1">Total arousal index</td><td rowspan="1" colspan="1">17.7 (11.5, 24.8)</td><td rowspan="1" colspan="1">20.2 (11.1, 40.5)</td><td rowspan="1" colspan="1">0.031*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1">Total AHI</td><td rowspan="1" colspan="1">17.6 (10.8, 30.7)</td><td rowspan="1" colspan="1">30.1 (14.5, 61.4)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1">NREM AHI</td><td rowspan="1" colspan="1">16.4 (8.8, 28.3)</td><td rowspan="1" colspan="1">26.4 (11.1, 61.1)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1">REM AHI</td><td rowspan="1" colspan="1">21.7 (10.9, 38.6)</td><td rowspan="1" colspan="1">41.55 (21, 64.9)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1">SpO<sub>2</sub> Awake average</td><td rowspan="1" colspan="1">94 (93, 95)</td><td rowspan="1" colspan="1">94 (93, 95)</td><td rowspan="1" colspan="1">0.015*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1">SpO<sub>2</sub> NREM average</td><td rowspan="1" colspan="1">94 (92, 95)</td><td rowspan="1" colspan="1">93 (91, 94)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1">SpO<sub>2</sub> REM average</td><td rowspan="1" colspan="1">94 (92, 95)</td><td rowspan="1" colspan="1">93 (89, 94)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1">SpO<sub>2</sub> Total average</td><td rowspan="1" colspan="1">94 (93, 95)</td><td rowspan="1" colspan="1">93 (91, 94)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1">SpO<sub>2</sub> Minimum</td><td rowspan="1" colspan="1">84 (79, 87)</td><td rowspan="1" colspan="1">80 (71, 85)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr></tbody></table><table-wrap-foot><fn id="tfn0007"><p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="neither"> Data presented as median (IQR). p-value</citation_analysis><citation_analysis attribute="positive"><sup>a</sup></citation_analysis><citation_analysis attribute="neither"> – p-value for equality of medians test. p-value</citation_analysis><citation_analysis attribute="positive"><sup>b</sup></citation_analysis><citation_analysis attribute="positive"> – p-value for Wilcoxon rank-sum equality of distributions test. *Denotes statistically significant (p&lt;0.05) differences.</citation_analysis></p></fn><fn id="tfn0008"><p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="neither"> POSA, positional sleep apnea; REM, rapid eye movement; NREM-N1, N2, N3, non-rapid eye movement sleep stage; NREM, non-rapid eye movement; AHI, Apnea-Hypopnea Index; SpO</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">, oxygen saturation.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><fig id="f0002" fig-type="figure" orientation="portrait" position="float"><label>Figure 2</label><caption><p><citation_analysis attribute="neither">Kernel density plots of oxygen saturation for POSA and non-POSA participants.</citation_analysis></p></caption><graphic content-type="print-only" xlink:href="NSS-12-1123-g0002"/><attrib><bold>Notes:</bold> Average values for SpO, awake (top left), SpO, NREM (top right), SpO, REM (mid left), SpO, total (mid right), SpO, minimum (bottom left).</attrib><attrib><bold>Abbreviations:</bold> NREM, non-rapid eye movement; POSA, positional sleep apnea; REM, rapid eye movement.</attrib></fig></citation_analysis></p>
      </sec>
      <sec id="s0003-s2003">
        <title>Treatment Simulation</title>
        <p><citation_analysis attribute="positive">Treatment was simulated and assessed only among patients who demonstrated to have POSA (</citation_analysis><citation_analysis attribute="positive"><xref rid="t0005" ref-type="table">Table 5</xref></citation_analysis><citation_analysis attribute="positive">). Significant differences were noted for the majority of parameters between PT and CPAP therapy. PT consistently resulted in significantly lesser reductions in AHI across each severity level (p&lt;0.001); however, differences compared to pre-treatment simulation were still significant. Among participants with mild OSA severity and POSA, simulated PT resulted in almost half of participants fully recovering (44% vs 77% PT and CPAP, respectively, p&lt;0.001). Among participants with either moderate or severe POSA, the vast majority (77% and 84%, respectively) demonstrated reductions in OSA severity; however, this was significantly smaller than for CPAP simulation (100% and 98%, respectively, p&lt;0.001). Overall, PT simulation demonstrated clinical improvement for two-thirds (65%) of patients with POSA.</citation_analysis><citation_analysis attribute="positive"><table-wrap id="t0005" orientation="portrait" position="float"><label>Table 5</label><caption><p><citation_analysis attribute="neither">Effects of Treatment Simulation for Participants with POSA Using Either PT or CPAP by Severity of OSA</citation_analysis></p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1">OSA Severity</th><th rowspan="1" colspan="1">Positional Therapy</th><th rowspan="1" colspan="1">CPAP</th><th rowspan="1" colspan="1">p-value<sup>a</sup></th><th rowspan="1" colspan="1">p-value<sup>b</sup></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"><bold>Mild (n=210)</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Post-simulation AHI</td><td rowspan="1" colspan="1">5.28 (4.01, 6.7)</td><td rowspan="1" colspan="1">3.98 (2.92, 4.8)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1"> AHI Difference</td><td rowspan="1" colspan="1">4.3 (2.8, 6.01)</td><td rowspan="1" colspan="1">5.97 (4.38, 7.2)</td><td rowspan="1" colspan="1">0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1"> Mild to Nil OSA</td><td rowspan="1" colspan="1">92 (44%)</td><td rowspan="1" colspan="1">162 (77%)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1"> Any reduction in level</td><td rowspan="1" colspan="1">92 (44%)</td><td rowspan="1" colspan="1">162 (77%)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1"><bold>Moderate (n=157)</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Post-simulation AHI</td><td rowspan="1" colspan="1">10.86 (9.24, 13.71)</td><td rowspan="1" colspan="1">8.68 (7.12, 10.24)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1"> AHI Difference</td><td rowspan="1" colspan="1">9.93 (7.68, 12.74)</td><td rowspan="1" colspan="1">13.02 (10.68, 15.36)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1"> Mod. To nil OSA</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1"> Mod. To Mild OSA</td><td rowspan="1" colspan="1">132 (84%)</td><td rowspan="1" colspan="1">157 (100%)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1"> Any reduction in level</td><td rowspan="1" colspan="1">132 (84%)</td><td rowspan="1" colspan="1">157 (100%)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1"><bold>Severe (n=128)</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Post-simulation AHI</td><td rowspan="1" colspan="1">22.57 (18.46, 29.33)</td><td rowspan="1" colspan="1">15.8 (13.72, 19.46)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1"> AHI Difference</td><td rowspan="1" colspan="1">18.67 (14.01, 23.08)</td><td rowspan="1" colspan="1">23.7 (20.58, 29.19)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1"> Severe to Nil OSA</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">0 (0%)</td><td rowspan="1" colspan="1">–</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1"> Severe to Mild OSA</td><td rowspan="1" colspan="1">14 (11%)</td><td rowspan="1" colspan="1">51 (40%)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1"> Severe to Mod. OSA</td><td rowspan="1" colspan="1">85 (66%)</td><td rowspan="1" colspan="1">74 (58%)</td><td rowspan="1" colspan="1">0.156</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1"> Any reduction in level</td><td rowspan="1" colspan="1">99 (77%)</td><td rowspan="1" colspan="1">125 (98%)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">–</td></tr><tr><td rowspan="1" colspan="1"><bold>Total POSA (n=495)</bold></td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1"> Post-simulation AHI</td><td rowspan="1" colspan="1">9.42 (5.65, 16.61)</td><td rowspan="1" colspan="1">7.04 (4.32, 12.28)</td><td rowspan="1" colspan="1">0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1"> AHI Difference</td><td rowspan="1" colspan="1">7.78 (4.54, 13.48)</td><td rowspan="1" colspan="1">10.56 (6.48, 18.42)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">&lt;0.001*</td></tr><tr><td rowspan="1" colspan="1"> Any reduction in level</td><td rowspan="1" colspan="1">323 (65%)</td><td rowspan="1" colspan="1">444 (90%)</td><td rowspan="1" colspan="1">&lt;0.001*</td><td rowspan="1" colspan="1">–</td></tr></tbody></table><table-wrap-foot><fn id="tfn0009"><p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="neither"> Data presented as median (IQR) and number (%). –value</citation_analysis><citation_analysis attribute="positive"><sup>a</sup></citation_analysis><citation_analysis attribute="neither"> – p-value for equality of medians test. p-value</citation_analysis><citation_analysis attribute="positive"><sup>b</sup></citation_analysis><citation_analysis attribute="positive"> – p-value for Wilcoxon rank-sum equality of distributions test. *Denotes statistically significant (p&lt;0.05) differences. PT simulation assumed 60% efficiency, thereby reducing time slept in supine position and reducing supine AHI by 40%: CPAP simulation assumed 60% efficiency, thereby reducing total AHI by 40%.</citation_analysis></p></fn><fn id="tfn0010"><p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="positive"> AHI, Apnea-Hypopnea Index; CPAP, continuous positive airway pressure; OSA, obstructive sleep apnea; POSA, positional obstructive sleep apnea; PT, positional therapy.</citation_analysis></p></fn></table-wrap-foot></table-wrap></citation_analysis><citation_analysis attribute="positive">
</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0004">
      <title>Discussion</title>
      <p><citation_analysis attribute="positive">Our study demonstrates that POSA is prevalent among Australian adult males and more so among non-Indigenous Australians. POSA was also noted to be associated with alcohol consumption, among those with lowish BMI and with milder severity of OSA. Model simulation showed PT is beneficial not only among those with milder severity of OSA but also amongst patients with moderate to severe OSA.</citation_analysis></p>
      <p><citation_analysis attribute="positive">Previous studies in the Australian setting, including studies from our centre, have shown that OSA is highly prevalent in this population.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0030" ref-type="bibr">30–33</xref></citation_analysis><citation_analysis attribute="neither"> However, studies exploring the prevalence of POSA and the impact on PT have been sparse in this regional and remote Australian population, especially among the NT Australian cohort. Hence, we believe our study may be of value in understanding the demographic, clinical and PSG profile of POSA in this population. In this study, POSA was noted in 61%, in line with previous reports</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11–14</xref></citation_analysis><citation_analysis attribute="neither"> and was predominantly noted among males (62%) and in non-Indigenous Australians (92%). This translates to three in every five patients with OSA have POSA and thus may merit greater focus and interventions. Although the number of Indigenous Australians in the current study was relatively small, it was enough to note a significantly reduced prevalence of POSA in comparison to non-Indigenous Australians (though this effect was alleviated in multivariate regression analysis). Indigenous Australian patients generally have a higher severity of OSA</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="positive"> and higher BMI, which may thus be the reason for lesser likelihood of POSA, and the reason for the amelioration of significance in multivariate analysis. There exists evidence in the literature for differences in POSA prevalence among differing ethnicities, most notably a potential increased prevalence among patients of Asian ethnicity compared to Caucasian, which may be related to differences in the craniofacial structure.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0011" ref-type="bibr">11–16</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="positive"> Further evidence from direct correlation studies however is lacking.</citation_analysis></p>
      <p><citation_analysis attribute="positive">In the current study, a significantly higher proportion of participants with POSA were male in comparison to those without POSA. The gender differences in the clinical manifestations OSA are documented in the literature, including body position that may influence the presence and severity of OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37–39</xref></citation_analysis><citation_analysis attribute="neither"> The reason for this difference is not clear, but probably a reflection of the differences in adipose tissue distribution between the two genders.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0040" ref-type="bibr">40–42</xref></citation_analysis><citation_analysis attribute="neither"> It was beyond the scope of the current study to explore the underlying POSA gender difference in detail; however, future research may be warranted.</citation_analysis></p>
      <p><citation_analysis attribute="neither">We also observed POSA was more prevalent among patients with self-reported alcohol consumption history. Alcohol consumption is known to increase the likelihood to OSA,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0043" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither"> but its relationship with POSA has been sparingly explored. However, it may be reasonable to speculate that alcohol may suppress the arousal response to upper airway obstruction during sleep, hence, suppressing the natural response to change in body position during an apnoeic episode, in turn facilitating higher episodes of POSA with alcohol consumption. Furthermore, alcohol may exert its action on upper airway dilator muscles and also alcohol may be associated with central adiposity with subsequently increasing diaphragm pressure and increasing upper airway collapsibility.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0044" ref-type="bibr">44</xref></citation_analysis></p>
      <p><citation_analysis attribute="neither">Our study, in line with the majority of previous literature reporting on prevalence of POSA and the severity of OSA, found the prevalence of POSA was higher in patients with milder OSA and reduced with increasing severity of the OSA.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0012" ref-type="bibr">12–14</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0016" ref-type="bibr">16</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0028" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0029" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0037" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0045" ref-type="bibr">45</xref></citation_analysis><citation_analysis attribute="positive"> It is likely that as the disease severity progresses the positional variability of the obstructive events is lost, and events start being observed in all body positions.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0047" ref-type="bibr">47</xref></citation_analysis><citation_analysis attribute="neither"> This may also be the reason that POSA is more commonly observed in patients with lower BMI, as BMI generally correlates with OSA severity.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0031" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0032" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0041" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0046" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0047" ref-type="bibr">47</xref></citation_analysis><citation_analysis attribute="neither"> Moreover, in our study, the PSG parameters showed POSA patients had higher NREM stage N2, N3 sleep and higher oxygen saturation, which could also be a reflection of this milder disease severity in this group.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Despite CPAP being established as a gold standard treatment modality for moderate to severe OSA, adherence to CPAP has consistently been noted to be low.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0024" ref-type="bibr">24</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0045" ref-type="bibr">45</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0048" ref-type="bibr">48–50</xref></citation_analysis><citation_analysis attribute="positive"> The simulation model in our study illustrates that PT may be beneficial in most patients with POSA, even among patients with moderate to severe OSA. The overall simulated PT impact in this group of patients, although lesser than that of CPAP, still resulted in two-thirds of patients demonstrating clinically significant improvement. Furthermore, simulated PT resulted in almost half (44%) of POSA patients reducing their AHI’s to &lt;5, and thus no longer being classified as having any form of OSA. This highlights the potential role of PT in the management of OSA,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0051" ref-type="bibr">51</xref></citation_analysis><citation_analysis attribute="positive"> especially in patients who are unwilling to use, unable to adopt/adhere/tolerate/limited access or afford CPAP therapy. Nevertheless, in general, adherence to earlier forms of PT including using traditional tennis ball technique have been low as well.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0052" ref-type="bibr">52</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0053" ref-type="bibr">53</xref></citation_analysis><citation_analysis attribute="neither"> However, the long-term adherence to PT has improved in the recent past with the use of newer generation devices that appear to be much more comfortable and acceptable/applicable.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0054" ref-type="bibr">54–60</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Our study has shown that POSA is prevalent in this regional and remote Australian population studied and the simulated PT model demonstrates that PT may be beneficial among not only in patients with milder OSA but also among those with moderate to severe OSA and PT could be a potential alternate modality in treating OSA, especially among patients who may have difficulty in the affordability/accessibility or intolerant to CPAP therapy. Further prospective research using novel PT devices is however warranted in this population.</citation_analysis></p>
      <sec id="s0004-s2001">
        <title>Study Limitations</title>
        <p><citation_analysis attribute="positive">This is a retrospective study of 946 patients from a single centre observed on a single night; thus, the findings may not be generalized. Australian Indigenous patients (8%) may be under-represented in this study to judge the true impact of ethnic status on POSA determinants. The number of patients from rural and remote region represented in this study was less in comparison to patients living in urban area. This may also indicate that access to health-care service may be limited in patients living in remote communities. Females constituted 38% of our patients and this may have some impact on the assessment of gender on POSA as well. We have used one of the common Cartwright criteria of POSA and the results may vary if other criteria were used. In our simulation protocol we assumed that by using PT, supine sleep time is reduced to 40%, although the recent PT studies have reported almost 84% reduction in supine sleep.</citation_analysis><citation_analysis attribute="positive"><xref rid="cit0049" ref-type="bibr">49</xref></citation_analysis><citation_analysis attribute="neither"> Our study assumed 60% compliance to CPAP which may vary in different clinical scenarios impacting the results. Despite these limitations, the study illustrates that POSA is extremely common and PT can benefit some of these patients.</citation_analysis></p>
      </sec>
    </sec>
    <sec id="s0005">
      <title>Conclusion</title>
      <p><citation_analysis attribute="positive">Our study highlights, POSA is highly prevalent in the adult Australian population in this region. Positional therapies may provide a viable alternative to number of OSA patients. This may potentially change our treatment paradigm for OSA and may provide a significant advantage in health-care cost.</citation_analysis></p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p><citation_analysis attribute="neither">We extend our sincere gratitude to the administrative staff Ms Tiziana Buysman, Mrs. Elisha Gamorot and sleep technologist Ms. Charmain Atos, Ms. Ara Perez, Mr. Jessie Crespo, Mr. Mark Ramirez and Ms. Bianca Al-Dossary at Darwin Respiratory and sleep health for their contribution towards this study. We also thank Dr David Cunnington, Respiratory and Sleep specialist from the Melbourne Sleep Disorders Centre, Victoria Pde, East Melbourne VIC, Australia for his expert opinion and advice.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Institution where work was performed: Department of Respiratory and Sleep Medicine, Royal Darwin Hospital, Darwin, Northern Territory, Australia and Darwin Respiratory and Sleep Health, Darwin Private Hospital, Darwin, Northern Territory, Australia. 0810.</citation_analysis></p>
    </ack>
    <sec id="s0006">
      <title>Abbreviations</title>
      <p><citation_analysis attribute="positive">AHI, Apnea-Hypopnea Index; ASA, Australian Sleep Association; ATSI, Aboriginal and/or Torres Strait Islander; BMI, body mass index; CI, confidence interval; CPAP, continuous positive airway therapy; DPH, Darwin Private Hospital; DRSH, Darwin Respiratory and Sleep Health; ESS, Epworth Sleepiness Scale; HREC, Human Research Ethics Committee; IQRs, interquartile ranges; NATA, National Association of Testing Authorities; NT, Northern Territory; ORs, odds ratios; OSA, obstructive sleep apnea; POSA, positional sleep apnea; PPs, positional patients; PSG, polysomnography; PT, positional therapy; RA, Regional Australia; RDH, Royal Darwin Hospital; REM, rapid eye movement; NREM, non rapid eye movement; TEHS, Top End Health Service.</citation_analysis></p>
    </sec>
    <sec id="s0007">
      <title>Summary</title>
      <p><citation_analysis attribute="positive">Sleep apnea is a global epidemic that is being increasingly recognised around the world, including among various socioeconomic groups and people living in remote and regional areas of Australia. Currently, the major treatment modality for sleep apnea has been the use of continuous positive airway therapy device and the applicability/monitoring of which poses many logistic challenges to those who have lesser access to health-care services. A phenotypic variant of sleep apnea is “positional sleep apnea”, where the apneas are predominantly noted during certain body positions. Altering the body position during sleep may help in alleviating the apnoeic episodes. However, there is sparse evidence in the literature regarding the prevalence or the effects of positional therapy in the regional and remote Australian population. Our study has demonstrated that positional sleep apnea is highly prevalent in the regional and remote adult Australian population and more commonly noted among males, younger adults, individuals who consume alcohol and in those with a lower body mass index and patients who display lesser overall severity of sleep apnea. Moreover, the model simulation of positional treatment effect in our study shows that positional treatment may be a promising alternate effective therapeutic modality that could help in the treatment paradigm for sleep apnea among vulnerable and underprivileged populations around the world.</citation_analysis></p>
    </sec>
    <sec id="s0008">
      <title>Author Contributions</title>
      <p><citation_analysis attribute="positive">All authors made a significant contribution to the work reported, whether that is in the conception, study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.</citation_analysis></p>
    </sec>
    <sec id="s0009" sec-type="COI-statement">
      <title>Disclosure</title>
      <p><citation_analysis attribute="neither">All authors declare no conflicts of interest.</citation_analysis></p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="cit0001">
        <label>1.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Senaratna</surname>
<given-names>CV</given-names></string-name>, <string-name><surname>Perret</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Lodge</surname>
<given-names>CJ</given-names></string-name>, et al. <article-title>Prevalence of obstructive sleep apnea in the general population: a systematic review</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2017</year>;<volume>34</volume>:<fpage>70</fpage>–<lpage>81</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2016.07.002</pub-id><pub-id pub-id-type="pmid">27568340</pub-id></mixed-citation>
      </ref>
      <ref id="cit0002">
        <label>2.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Benjafield</surname>
<given-names>AV</given-names></string-name>, <string-name><surname>Ayas</surname>
<given-names>NT</given-names></string-name>, <string-name><surname>Eastwood</surname>
<given-names>PR</given-names></string-name>, et al. <article-title>Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis</article-title>. <source><italic toggle="yes">Lancet Respir Med</italic></source>. <year>2019</year>;<volume>7</volume>:<fpage>687</fpage>–<lpage>698</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S2213-2600(19)30198-5</pub-id><pub-id pub-id-type="pmid">31300334</pub-id></mixed-citation>
      </ref>
      <ref id="cit0003">
        <label>3.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Peppard</surname>
<given-names>PE</given-names></string-name>, <string-name><surname>Young</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Palta</surname>
<given-names>M</given-names></string-name>, et al. <article-title>Prospective study of the association between sleep-disordered breathing and hypertension</article-title>. <source><italic toggle="yes">N Engl J Med</italic></source>. <year>2000</year>;<volume>342</volume>:<fpage>1378</fpage>–<lpage>1384</lpage>.<pub-id pub-id-type="pmid">10805822</pub-id></mixed-citation>
      </ref>
      <ref id="cit0004">
        <label>4.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Leung</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Bradley</surname>
<given-names>TD</given-names></string-name>. <article-title>Sleep apnea and cardiovascular disease</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2001</year>;<volume>164</volume>:<fpage>2147</fpage>–<lpage>2165</lpage>. doi:<pub-id pub-id-type="doi">10.1164/ajrccm.164.12.2107045</pub-id><pub-id pub-id-type="pmid">11751180</pub-id></mixed-citation>
      </ref>
      <ref id="cit0005">
        <label>5.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kasai</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Floras</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Bradley</surname>
<given-names>TD</given-names></string-name>. <article-title>Sleep apnea and cardiovascular disease: a bidirectional relationship</article-title>. <source><italic toggle="yes">Circulation</italic></source>. <year>2012</year>;<volume>126</volume>:<fpage>1495</fpage>–<lpage>1510</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.070813</pub-id><pub-id pub-id-type="pmid">22988046</pub-id></mixed-citation>
      </ref>
      <ref id="cit0006">
        <label>6.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Marshall</surname>
<given-names>NS</given-names></string-name>, <string-name><surname>Wong</surname>
<given-names>KKH</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>PY</given-names></string-name>, et al. <article-title>Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2008</year>;<volume>31</volume>:<fpage>1079</fpage>–<lpage>1086</lpage>.<pub-id pub-id-type="pmid">18714779</pub-id></mixed-citation>
      </ref>
      <ref id="cit0007">
        <label>7.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Deacon</surname>
<given-names>NL</given-names></string-name>, <string-name><surname>Jen</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Y</given-names></string-name>, et al. <article-title>Treatment of obstructive sleep apnea prospects for personalized combined modality therapy</article-title>. <source><italic toggle="yes">Ann Am Thorac Soc</italic></source>. <year>2016</year>;<volume>13</volume>:<fpage>101</fpage>–<lpage>108</lpage>. doi:<pub-id pub-id-type="doi">10.1513/AnnalsATS.201508-537FR</pub-id><pub-id pub-id-type="pmid">26569377</pub-id></mixed-citation>
      </ref>
      <ref id="cit0008">
        <label>8.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zinchuk</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Yaggi</surname>
<given-names>HY</given-names></string-name>. <article-title>Phenotypic subtypes of OSA. A challenge and opportunity for precision medicine</article-title>. <source><italic toggle="yes">Chest.</italic></source>
<year>2020</year>;<volume>157</volume>:<fpage>403</fpage>–<lpage>420</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2019.09.002</pub-id><pub-id pub-id-type="pmid">31539538</pub-id></mixed-citation>
      </ref>
      <ref id="cit0009">
        <label>9.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Cartwright</surname>
<given-names>RD</given-names></string-name>. <article-title>Effect of sleep position on sleep apnea severity</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>1984</year>;<volume>7</volume>:<fpage>110</fpage>–<lpage>1114</lpage>.<pub-id pub-id-type="pmid">6740055</pub-id></mixed-citation>
      </ref>
      <ref id="cit0010">
        <label>10.</label>
        <mixed-citation publication-type="book"><string-name><surname>Berry</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Albertario</surname>
<given-names>CL</given-names></string-name>, <string-name><surname>Harding</surname>
<given-names>SM</given-names></string-name>, et al. <article-title>For the American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: rules, Terminology and Technical Specifications. Version 2.5</article-title>. <publisher-loc>Darien, IL</publisher-loc>: <publisher-name>American Academy of Sleep Medicine</publisher-name>; <year>2018</year>.</mixed-citation>
      </ref>
      <ref id="cit0011">
        <label>11.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Iannella</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Magliulo</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Lo Iacono</surname>
<given-names>CAM</given-names></string-name>, et al. <article-title>Positional Obstructive sleep apnea syndrome in elderly patients</article-title>. <source><italic toggle="yes">Int J Environ Res Public Health</italic></source>. <year>2020</year>;<volume>17</volume>:<fpage>1120</fpage>. doi:<pub-id pub-id-type="doi">10.3390/ijerph17031120</pub-id></mixed-citation>
      </ref>
      <ref id="cit0012">
        <label>12.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Heinzer</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Petitpierre</surname>
<given-names>NJ</given-names></string-name>, <string-name><surname>Marti-Soler</surname>
<given-names>H</given-names></string-name>, et al. <article-title>Prevalence and characteristics of positional sleep apnea in the HypnoLaus population-based cohort</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2018</year>;<volume>48</volume>:<fpage>157</fpage>–<lpage>162</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2018.02.011</pub-id><pub-id pub-id-type="pmid">29957486</pub-id></mixed-citation>
      </ref>
      <ref id="cit0013">
        <label>13.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jorquera</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Labarca</surname>
<given-names>TG</given-names></string-name>, <string-name><surname>Dreyse</surname>
<given-names>DJ</given-names></string-name>, et al. <article-title>Clinical differences in positional obstructive sleep apnea patients</article-title>. <source><italic toggle="yes">Rev Chil de Enfermedades Respir</italic></source>. <year>2017</year>;<volume>33</volume>:<fpage>14</fpage>–<lpage>20</lpage>.</mixed-citation>
      </ref>
      <ref id="cit0014">
        <label>14.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Laub</surname>
<given-names>RR</given-names></string-name>, <string-name><surname>Mikkelsen</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Tønnesen</surname>
<given-names>P</given-names></string-name>. <article-title>Prevalence of positional obstructive sleep apnea and patients characteristics using various definitions</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2015</year>;<volume>46</volume>:<fpage>PA2372</fpage>. doi:<pub-id pub-id-type="doi">10.1183/13993003.congress-2015.PA2372</pub-id></mixed-citation>
      </ref>
      <ref id="cit0015">
        <label>15.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Olabimpe</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Quan</surname>
<given-names>SF</given-names></string-name>. <article-title>Positional therapy in the management of positional obstructive sleep apnea—a review of the current literature</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2018</year>;<volume>22</volume>:<fpage>297</fpage>–<lpage>304</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-017-1561-y</pub-id><pub-id pub-id-type="pmid">28852945</pub-id></mixed-citation>
      </ref>
      <ref id="cit0016">
        <label>16.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Oksenberg</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Gadoth</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Töyräs</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Prevalence and characteristics of positional obstructive sleep apnea (POSA) in patients with severe OSA</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2020</year>;<volume>24</volume>:<fpage>551</fpage>–<lpage>559</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-019-01897-1</pub-id><pub-id pub-id-type="pmid">31325020</pub-id></mixed-citation>
      </ref>
      <ref id="cit0017">
        <label>17.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Streatfeild</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Hillman</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Adams</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Cost-effectiveness of continuous positive airway pressure therapy for obstructive sleep apnea: health care system and societal perspectives</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2019</year>;<volume>42</volume>(<issue>12</issue>):<page-range>pii: zsz181</page-range>. doi:<pub-id pub-id-type="doi">10.1093/sleep/zsz181</pub-id></mixed-citation>
      </ref>
      <ref id="cit0018">
        <label>18.</label>
        <mixed-citation publication-type="journal"><string-name><surname>McEvoy</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Antic</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Heeley</surname>
<given-names>E</given-names></string-name>, et al. <article-title>CPAP for prevention of cardiovascular events in obstructive sleep apnea</article-title>. <source><italic toggle="yes">N Engl J Med</italic></source>. <year>2016</year>;<volume>375</volume>:<fpage>919</fpage>–<lpage>931</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa1606599</pub-id><pub-id pub-id-type="pmid">27571048</pub-id></mixed-citation>
      </ref>
      <ref id="cit0019">
        <label>19.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Zozula</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Rosen</surname>
<given-names>R</given-names></string-name>. <article-title>Compliance with continuous positive airway pressure therapy: assessing and improving treatment outcomes</article-title>. <source><italic toggle="yes">Curr Opin Pulm Med</italic></source>. <year>2001</year>;<volume>7</volume>:<fpage>391</fpage>–<lpage>398</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00063198-200111000-00005</pub-id><pub-id pub-id-type="pmid">11706314</pub-id></mixed-citation>
      </ref>
      <ref id="cit0020">
        <label>20.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ulander</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Johansson</surname>
<given-names>MS</given-names></string-name>, <string-name><surname>Ewaldh</surname>
<given-names>AE</given-names></string-name>, et al. <article-title>Side effects to continuous positive airway pressure treatment for obstructive sleep apnoea: changes over time and association to adherence</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2014</year>;<volume>18</volume>:<fpage>799</fpage>–<lpage>807</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-014-0945-5</pub-id><pub-id pub-id-type="pmid">24557772</pub-id></mixed-citation>
      </ref>
      <ref id="cit0021">
        <label>21.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Weaver</surname>
<given-names>TE</given-names></string-name>, <string-name><surname>Sawyer</surname>
<given-names>AM</given-names></string-name>. <article-title>Adherence to continuous positive airway pressure treatment for obstructive sleep apnoea: implications for future interventions</article-title>. <source><italic toggle="yes">Indian J Med Res</italic></source>. <year>2010</year>;<volume>131</volume>:<fpage>245</fpage>–<lpage>258</lpage>.<pub-id pub-id-type="pmid">20308750</pub-id></mixed-citation>
      </ref>
      <ref id="cit0022">
        <label>22.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Yang</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>Lan</surname>
<given-names>CC</given-names></string-name>, et al. <article-title>Factors affecting CPAP acceptance in elderly patients with obstructive sleep apnea in Taiwan</article-title>. <source><italic toggle="yes">Respir Care</italic></source>. <year>2013</year>;<volume>58</volume>:<fpage>1504</fpage>–<lpage>1513</lpage>. doi:<pub-id pub-id-type="doi">10.4187/respcare.02176</pub-id><pub-id pub-id-type="pmid">23431309</pub-id></mixed-citation>
      </ref>
      <ref id="cit0023">
        <label>23.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Weaver</surname>
<given-names>TE</given-names></string-name>, <string-name><surname>Grunstein</surname>
<given-names>RR</given-names></string-name>. <article-title>Adherence to continuous positive airway pressure therapy: the challenge to effective treatment</article-title>. <source><italic toggle="yes">Proc Am Thorac Soc</italic></source>. <year>2008</year>;<volume>5</volume>:<fpage>173</fpage>–<lpage>178</lpage>. doi:<pub-id pub-id-type="doi">10.1513/pats.200708-119MG</pub-id><pub-id pub-id-type="pmid">18250209</pub-id></mixed-citation>
      </ref>
      <ref id="cit0024">
        <label>24.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Rotenberg</surname>
<given-names>BW</given-names></string-name>, <string-name><surname>Murariu</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Pang</surname>
<given-names>KP</given-names></string-name>. <article-title>Trends in CPAP adherence over twenty years of data collection: a flattened curve</article-title>. <source><italic toggle="yes">J Otolaryngol Head Neck Surg</italic></source>. <year>2016</year>;<volume>45</volume>:<fpage>43</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40463-016-0156-0</pub-id><pub-id pub-id-type="pmid">27542595</pub-id></mixed-citation>
      </ref>
      <ref id="cit0025">
        <label>25.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kendzerska</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Mollayeva</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Gershon</surname>
<given-names>AS</given-names></string-name>, et al. <article-title>Untreated obstructive sleep apnea and the risk for serious long-term adverse outcomes: a systematic review</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2014</year>;<volume>18</volume>:<fpage>49</fpage>–<lpage>59</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2013.01.003</pub-id><pub-id pub-id-type="pmid">23642349</pub-id></mixed-citation>
      </ref>
      <ref id="cit0026">
        <label>26.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Simon-Tuval</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Reuveni</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Greenberg-Dotan</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Low socioeconomic status is a risk factor for CPAP acceptance among adult OSAS patients requiring treatment</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2009</year>;<volume>32</volume>:<fpage>545</fpage>–<lpage>552</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/32.4.545</pub-id><pub-id pub-id-type="pmid">19413149</pub-id></mixed-citation>
      </ref>
      <ref id="cit0027">
        <label>27.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lee</surname>
<given-names>CHK</given-names></string-name>, <string-name><surname>Leow</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>Song</surname>
<given-names>PR</given-names></string-name>, et al. <article-title>Acceptance and adherence to continuous positive airway pressure therapy in patients with obstructive sleep apnea (OSA) in a Southeast Asian privately funded healthcare system</article-title>. <source><italic toggle="yes">Sleep Sci</italic></source>. <year>2017</year>;<volume>10</volume>:<fpage>57</fpage>–<lpage>63</lpage>. doi:<pub-id pub-id-type="doi">10.5935/1984-0063.20170010</pub-id><pub-id pub-id-type="pmid">28966740</pub-id></mixed-citation>
      </ref>
      <ref id="cit0028">
        <label>28.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Joosten</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>O’Driscoll</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Berger</surname>
<given-names>PJ</given-names></string-name>, et al. <article-title>Supine position related obstructive sleep apnea in adults: pathogenesis and treatment</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2014</year>;<volume>18</volume>:<fpage>7</fpage>–<lpage>17</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2013.01.005</pub-id><pub-id pub-id-type="pmid">23669094</pub-id></mixed-citation>
      </ref>
      <ref id="cit0029">
        <label>29.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Chou</surname>
<given-names>YT</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>CK</given-names></string-name>, et al. <article-title>Pay attention to treating a subgroup of positional obstructive sleep apnea patients</article-title>. <source><italic toggle="yes">J Formos Med Assoc</italic></source>. <year>2017</year>;<volume>116</volume>:<fpage>359</fpage>–<lpage>365</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jfma.2016.06.007</pub-id><pub-id pub-id-type="pmid">27451274</pub-id></mixed-citation>
      </ref>
      <ref id="cit0030">
        <label>30.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Adams</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Appleton</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>AW</given-names></string-name>, et al. <article-title>Sleep health of Australian adults in 2016: results of the 2016 Sleep Health Foundation national survey</article-title>. <source><italic toggle="yes">Sleep Health</italic></source>. <year>2017</year>;<volume>3</volume>:<fpage>35</fpage>–<lpage>42</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleh.2016.11.005</pub-id><pub-id pub-id-type="pmid">28346149</pub-id></mixed-citation>
      </ref>
      <ref id="cit0031">
        <label>31.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Mehra</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ghimire</surname>
<given-names>RH</given-names></string-name>, <string-name><surname>Joy</surname>
<given-names>J</given-names></string-name>, et al. <article-title>Gender differences in the clinical and polysomnographic characteristics among australian aboriginal patients with obstructive sleep apnea</article-title>. <source><italic toggle="yes">Nat Sci Sleep</italic></source>. <year>2020</year>;<volume>12</volume>:<fpage>593</fpage>–<lpage>602</lpage>. doi:<pub-id pub-id-type="doi">10.2147/NSS.S258330</pub-id><pub-id pub-id-type="pmid">32922104</pub-id></mixed-citation>
      </ref>
      <ref id="cit0032">
        <label>32.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Heraganahally</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Kruavit</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Oguoma</surname>
<given-names>VM</given-names></string-name>, et al. <article-title>Sleep apnoea among Australian Aboriginal and non-Aboriginal patients in the Northern Territory of Australia—a comparative study</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2020</year>;<volume>43</volume>(<issue>3</issue>):<fpage>zsz248</fpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/zsz248</pub-id><pub-id pub-id-type="pmid">31608397</pub-id></mixed-citation>
      </ref>
      <ref id="cit0033">
        <label>33.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kruavit</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Fox</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Pearson</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Chronic respiratory disease in the regional and remote population of the northern territory top end: a perspective from the specialist respiratory outreach service</article-title>. <source><italic toggle="yes">Aust J Rural Health</italic></source>. <year>2017</year>;<volume>25</volume>:<fpage>275</fpage>–<lpage>284</lpage>. doi:<pub-id pub-id-type="doi">10.1111/ajr.12349</pub-id><pub-id pub-id-type="pmid">28618108</pub-id></mixed-citation>
      </ref>
      <ref id="cit0034">
        <label>34.</label>
        <mixed-citation publication-type="web"><collab>Estimates of Aboriginal and Torres Strait Islander Australians</collab>. <article-title>Australian bureau of statistics</article-title>. <source>Canberra</source>; <month>6</month>
<year>2016</year>
<comment>Available from:</comment>
<ext-link ext-link-type="uri" xlink:href="https://www.abs.gov.au">https://www.abs.gov.au</ext-link>. <date-in-citation>Accessed <month>11</month><day>23</day>, 2020</date-in-citation>.</mixed-citation>
      </ref>
      <ref id="cit0035">
        <label>35.</label>
        <mixed-citation publication-type="book"><collab>Australian Bureau of Statistics</collab>. <article-title>Australian Statistical Geography Standard (ASGS): volume 5—Remoteness Structure, July 2011. ABS cat. no. 1270. 0.55.005</article-title>. <publisher-loc>Canberra</publisher-loc>: <publisher-name>Australian Bureau of Statistics</publisher-name>; <year>2013a</year>.</mixed-citation>
      </ref>
      <ref id="cit0036">
        <label>36.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Kulkas</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Leppänen</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Nikkonen</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Required CPAP usage time to normalize AHI in obstructive sleep apnea patients: a simulation study</article-title>. <source><italic toggle="yes">Physiol Meas</italic></source>. <year>2018</year>;<volume>39</volume>(<issue>11</issue>):<fpage>115009</fpage>. doi:<pub-id pub-id-type="doi">10.1088/1361-6579/aae7fe</pub-id><pub-id pub-id-type="pmid">30485257</pub-id></mixed-citation>
      </ref>
      <ref id="cit0037">
        <label>37.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Joosten</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Hamza</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Sands</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Phenotypes of patients with mild to moderate obstructive sleep apnoea as confirmed by cluster analysis</article-title>. <source><italic toggle="yes">Respirology</italic></source>. <year>2012</year>;<volume>17</volume>:<fpage>99</fpage>–<lpage>107</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1440-1843.2011.02037.x</pub-id><pub-id pub-id-type="pmid">21848707</pub-id></mixed-citation>
      </ref>
      <ref id="cit0038">
        <label>38.</label>
        <mixed-citation publication-type="journal"><string-name><surname>O’Connor</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Thornley</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>Hanly</surname>
<given-names>PJ</given-names></string-name>. <article-title>Gender differences in the polysomnographic features of obstructive sleep apnea</article-title>. <source><italic toggle="yes">Am J Respir Crit Care Med</italic></source>. <year>2000</year>;<volume>161</volume>:<fpage>1465</fpage>–<lpage>1472</lpage>. doi:<pub-id pub-id-type="doi">10.1164/ajrccm.161.5.9904121</pub-id><pub-id pub-id-type="pmid">10806140</pub-id></mixed-citation>
      </ref>
      <ref id="cit0039">
        <label>39.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lin</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Davidson</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Ancoli-Israel</surname>
<given-names>S</given-names></string-name>. <article-title>Gender differences in obstructive sleep apnea and treatment implications</article-title>. <source><italic toggle="yes">Sleep Med Rev</italic></source>. <year>2008</year>;<volume>12</volume>:<fpage>481</fpage>–<lpage>496</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.smrv.2007.11.003</pub-id><pub-id pub-id-type="pmid">18951050</pub-id></mixed-citation>
      </ref>
      <ref id="cit0040">
        <label>40.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Millman</surname>
<given-names>RP</given-names></string-name>, <string-name><surname>Carlisle</surname>
<given-names>CC</given-names></string-name>, <string-name><surname>McGarvey</surname>
<given-names>ST</given-names></string-name>, et al. <article-title>Body fat distribution and sleep apnea severity in women</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>1995</year>;<volume>107</volume>:<fpage>362</fpage>–<lpage>366</lpage>. doi:<pub-id pub-id-type="doi">10.1378/chest.107.2.362</pub-id><pub-id pub-id-type="pmid">7842762</pub-id></mixed-citation>
      </ref>
      <ref id="cit0041">
        <label>41.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Romero-Corral</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Caples</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Lopez-Jimenez</surname>
<given-names>F</given-names></string-name>, et al. <article-title>Interactions between obesity and obstructive sleep apnea: implications for treatment</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2010</year>;<volume>137</volume>:<fpage>711</fpage>–<lpage>719</lpage>. doi:<pub-id pub-id-type="doi">10.1378/chest.09-0360</pub-id><pub-id pub-id-type="pmid">20202954</pub-id></mixed-citation>
      </ref>
      <ref id="cit0042">
        <label>42.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Young</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Palta</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Dempsey</surname>
<given-names>J</given-names></string-name>, et al. <article-title>The occurrence of sleep disordered-breathing among middle aged adults</article-title>. <source><italic toggle="yes">N Engl J Med</italic></source>. <year>1993</year>;<volume>328</volume>:<fpage>1230</fpage>–<lpage>1235</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJM199304293281704</pub-id><pub-id pub-id-type="pmid">8464434</pub-id></mixed-citation>
      </ref>
      <ref id="cit0043">
        <label>43.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Simou</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Britton</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Leonardi-Bee</surname>
<given-names>J</given-names></string-name>. <article-title>Alcohol and the risk of sleep apnoea: a systematic review and meta-analysis</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2018</year>;<volume>42</volume>:<fpage>38</fpage>–<lpage>46</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2017.12.005</pub-id><pub-id pub-id-type="pmid">29458744</pub-id></mixed-citation>
      </ref>
      <ref id="cit0044">
        <label>44.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Stadler</surname>
<given-names>DL</given-names></string-name>, <string-name><surname>McEvoy</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Sprecher</surname>
<given-names>KE</given-names></string-name>, et al. <article-title>Abdominal compression increases upper airway collapsibility during sleep in obese male obstructive sleep apnea patients</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2009</year>;<volume>32</volume>:<fpage>1579</fpage>–<lpage>1587</lpage>. doi:<pub-id pub-id-type="doi">10.1093/sleep/32.12.1579</pub-id><pub-id pub-id-type="pmid">20041593</pub-id></mixed-citation>
      </ref>
      <ref id="cit0045">
        <label>45.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bouloukaki</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Pataka</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Steiropoulos</surname>
<given-names>P</given-names></string-name>, et al. <article-title>Positional obstructive sleep apnea in the European Sleep Apnoea Database (ESADA)</article-title>. <source><italic toggle="yes">Eur Respir J</italic></source>. <year>2018</year>;<volume>52</volume>:<fpage>PA4335</fpage>. doi:<pub-id pub-id-type="doi">10.1183/13993003.congress-2018.PA4335</pub-id></mixed-citation>
      </ref>
      <ref id="cit0046">
        <label>46.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Joosten</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Hamilton</surname>
<given-names>GS</given-names></string-name>, <string-name><surname>Naughton</surname>
<given-names>MT</given-names></string-name>. <article-title>Impact of weight loss management in OSA</article-title>. <source><italic toggle="yes">Chest</italic></source>. <year>2017</year>;<volume>152</volume>:<fpage>194</fpage>–<lpage>203</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.chest.2017.01.027</pub-id><pub-id pub-id-type="pmid">28185772</pub-id></mixed-citation>
      </ref>
      <ref id="cit0047">
        <label>47.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Joosten</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Khoo</surname>
<given-names>JK</given-names></string-name>, <string-name><surname>Edwards</surname>
<given-names>BA</given-names></string-name>, et al. <article-title>Improvement in obstructive sleep apnea with weight loss is dependent on body position during sleep</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2017</year>;<volume>40</volume>(<issue>5</issue>). <comment>PMID: 28444355</comment>. doi:<pub-id pub-id-type="doi">10.1093/sleep/zsx047</pub-id>.</mixed-citation>
      </ref>
      <ref id="cit0048">
        <label>48.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Heraganahally</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Zaw</surname>
<given-names>KK</given-names></string-name>, <string-name><surname>Tip</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Obstructive sleep apnoea and adherence to continuous positive airway therapy among Australian women</article-title>. <source><italic toggle="yes">Int Med J</italic></source>. <year>2020</year>. doi:<pub-id pub-id-type="doi">10.1111/imj.15076</pub-id></mixed-citation>
      </ref>
      <ref id="cit0049">
        <label>49.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Heraganahally</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>White</surname>
<given-names>S</given-names></string-name>. <article-title>A cost-effective novel innovative box (C-Box) to prevent cockroach infestation of continuous positive airway pressure equipment: a unique problem in Northern Tropical Australia</article-title>. <source><italic toggle="yes">Am J Trop Med Hyg</italic></source>. <year>2019</year>;<fpage>1</fpage>–<lpage>4</lpage>. doi:<pub-id pub-id-type="doi">10.4269/ajtmh.19-0434</pub-id></mixed-citation>
      </ref>
      <ref id="cit0050">
        <label>50.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Heraganahally</surname>
<given-names>SS</given-names></string-name>, <string-name><surname>Kerslake</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Issac</surname>
<given-names>S</given-names></string-name>, et al. <article-title>Outcome of public hospital-funded continuous positive airway therapy device for patients with obstructive sleep apnoea: an Australian Perspective Study</article-title>. <source><italic toggle="yes">Sleep Vigilance</italic></source>. <year>2020</year>. doi:<pub-id pub-id-type="doi">10.1007/s41782-020-00114-4</pub-id></mixed-citation>
      </ref>
      <ref id="cit0051">
        <label>51.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Joosten</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Edwards</surname>
<given-names>BA</given-names></string-name>, <string-name><surname>Wellman</surname>
<given-names>A</given-names></string-name>, et al. <article-title>The effect of body position on physiological factors that contribute to obstructive sleep apnea</article-title>. <source><italic toggle="yes">Sleep</italic></source>. <year>2015</year>;<volume>38</volume>:<fpage>1469</fpage>–<lpage>1478</lpage>. doi:<pub-id pub-id-type="doi">10.5665/sleep.4992</pub-id><pub-id pub-id-type="pmid">25761982</pub-id></mixed-citation>
      </ref>
      <ref id="cit0052">
        <label>52.</label>
        <mixed-citation publication-type="journal"><string-name><surname>de Vries</surname>
<given-names>GE</given-names></string-name>, <string-name><surname>Hoekema</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Doff</surname>
<given-names>MH</given-names></string-name>, et al. <article-title>Usage of positional therapy in adults with obstructive sleep apnea</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2015</year>;<volume>11</volume>:<fpage>131</fpage>–<lpage>137</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.4458</pub-id><pub-id pub-id-type="pmid">25406271</pub-id></mixed-citation>
      </ref>
      <ref id="cit0053">
        <label>53.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Bignold</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Deans-Costi</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Goldsworthy</surname>
<given-names>MR</given-names></string-name>, et al. <article-title>Poor long-term patient compliance with the tennis ball technique for treating positional obstructive sleep apnea</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2009</year>;<volume>5</volume>:<fpage>428</fpage>–<lpage>430</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.27597</pub-id><pub-id pub-id-type="pmid">19961026</pub-id></mixed-citation>
      </ref>
      <ref id="cit0054">
        <label>54.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Lorenzi-Filho</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Almeida</surname>
<given-names>FR</given-names></string-name>, <string-name><surname>Strollo</surname>
<given-names>PJ</given-names></string-name>. <article-title>Treating OSA: current and emerging therapies beyond CPAP</article-title>. <source><italic toggle="yes">Respirology</italic></source>. <year>2017</year>;<volume>22</volume>:<fpage>1500</fpage>–<lpage>1507</lpage>. doi:<pub-id pub-id-type="doi">10.1111/resp.13144</pub-id><pub-id pub-id-type="pmid">28901030</pub-id></mixed-citation>
      </ref>
      <ref id="cit0055">
        <label>55.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Jackson</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Collins</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Berlowitz</surname>
<given-names>D</given-names></string-name>, et al. <article-title>Efficacy of sleep position modification to treat positional obstructive sleep apnea</article-title>. <source><italic toggle="yes">Sleep Med</italic></source>. <year>2015</year>;<volume>16</volume>:<fpage>545</fpage>–<lpage>552</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.sleep.2015.01.008</pub-id><pub-id pub-id-type="pmid">25771294</pub-id></mixed-citation>
      </ref>
      <ref id="cit0056">
        <label>56.</label>
        <mixed-citation publication-type="journal"><string-name><surname>de Ruiter</surname>
<given-names>MHT</given-names></string-name>, <string-name><surname>Benoist</surname>
<given-names>LBL</given-names></string-name>, <string-name><surname>de Vries</surname>
<given-names>N</given-names></string-name>, et al. <article-title>Durability of treatment effects of the sleep position trainer versus oral appliance therapy in positional OSA: 12-month follow-up of a randomized controlled trial</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2018</year>;<volume>22</volume>:<fpage>441</fpage>–<lpage>450</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-017-1568-4</pub-id><pub-id pub-id-type="pmid">28913630</pub-id></mixed-citation>
      </ref>
      <ref id="cit0057">
        <label>57.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Levendowski</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Cunnington</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Swieca</surname>
<given-names>J</given-names></string-name>, et al. <article-title>User compliance and behavioral adaptation associated with supine avoidance therapy</article-title>. <source><italic toggle="yes">Behav Sleep Med</italic></source>. <year>2018</year>;<volume>16</volume>:<fpage>27</fpage>–<lpage>37</lpage>. doi:<pub-id pub-id-type="doi">10.1080/15402002.2016.1163704</pub-id><pub-id pub-id-type="pmid">27159044</pub-id></mixed-citation>
      </ref>
      <ref id="cit0058">
        <label>58.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Ravesloot</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>White</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Heinzer</surname>
<given-names>R</given-names></string-name>, et al. <article-title>Efficacy of the new generation of devices for positional therapy for patients with positional obstructive sleep apnea: a systematic review of the literature and meta-analysis</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2017</year>;<volume>13</volume>:<fpage>813</fpage>–<lpage>824</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.6622</pub-id><pub-id pub-id-type="pmid">28212691</pub-id></mixed-citation>
      </ref>
      <ref id="cit0059">
        <label>59.</label>
        <mixed-citation publication-type="journal"><string-name><surname>Beyers</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Vanderveken</surname>
<given-names>OM</given-names></string-name>, <string-name><surname>Kastoer</surname>
<given-names>C</given-names></string-name>, et al. <article-title>Treatment of sleep-disordered breathing with positional therapy: long-term results</article-title>. <source><italic toggle="yes">Sleep Breath</italic></source>. <year>2019</year>;<volume>23</volume>:<fpage>1141</fpage>–<lpage>1149</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s11325-019-01792-9</pub-id><pub-id pub-id-type="pmid">30778914</pub-id></mixed-citation>
      </ref>
      <ref id="cit0060">
        <label>60.</label>
        <mixed-citation publication-type="journal"><string-name><surname>De Corso</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Mastrapasqua</surname>
<given-names>RF</given-names></string-name>, <string-name><surname>Fiorita</surname>
<given-names>A</given-names></string-name>, et al. <article-title>Efficacy and long-term follow-up of positional therapy by vibrotactile neck-based device in the management of positional OSA</article-title>. <source><italic toggle="yes">J Clin Sleep Med</italic></source>. <year>2020</year>;<volume>16</volume>:<fpage>1711</fpage>–<lpage>1719</lpage>. doi:<pub-id pub-id-type="doi">10.5664/jcsm.8664</pub-id><pub-id pub-id-type="pmid">32621579</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
